The Role of Catalase in Pulmonary Fibrosis

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Odajima, Nao ^a   Betsuyaku, Tomoko ^a   Nagai, Katsura ^a   Moriyama, Chinatsu ^a   Wang, Da Hong ^b   Takigawa, Tomoko ^b   Ogino, Keiki ^b   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COLLAGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LUNG INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; ENZYMOLOGY; LUNG; METABOLISM; MIDDLE AGED; TISSUE DISTRIBUTION;

ANIMALS; CATALASE; FEMALE; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PULMONARY FIBROSIS; TISSUE DISTRIBUTION;

EID: 78650589918     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-183     Document Type: Article

References (50)

1. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277-304. American Thoracic Society/European Respiratory Society.
2. Mastruzzo C, Crimi N, Vancheri C. Role of oxidative stress in pulmonary fibrosis. Monaldi Arch Chest Dis 2002, 57:173-176.
3. Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005, 172:417-422. 10.1164/rccm.200501-017PP, 2718525, 15894605.
4. Kinnula VL, Myllärniemi M. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid Redox Signal 2008, 10:727-738. 10.1089/ars.2007.1942, 18177235.
5. Deisseroth A, Dounce AL. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970, 50:319-375.
6. Zamocky M, Furtmüller PG, Obinger C. Evolution of catalases from bacteria to humans. Antioxid Redox Signal 2008, 10:1527-1548. 10.1089/ars.2008.2046, 2959186, 18498226.
7. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911. 10.1126/science.1106653, 15879174.
8. Nomura K, Imai H, Koumura T, Arai M, Nakagawa Y. Mitochondrial phospholipids hydroperoxide glutathione peroxidase suppresses apoptosis mediated by a mitochondrial death pathway. J Biol Chem 1999, 274:29294-29302. 10.1074/jbc.274.41.29294, 10506188.
9. Arita Y, Harkness SH, Kazzaz JA, Koo HC, Joseph A, Melendez JA, Davis JM, Chander A, Li Y. Mitochondrial localization of catalase provides optimal protection from H2O2-induced cell death in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 290:L978-986. 10.1152/ajplung.00296.2005, 16387755.
10. Yoo JH, Erzurum SC, Hay JG, Lemarchand P, Crystal RG. Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest 1994, 93:297-302. 10.1172/JCI116959, 293765, 8282800.
11. Coursin DB, Cihla HP, Sempf J, Oberley TD, Oberley LW. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 1996, 11:851-860.
12. Kaarteenaho-Wiik R, Kinnula VL. Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J Histochem Cytochem 2004, 52:1231-1240. 10.1369/jhc.4A6291.2004, 15314090.
13. Lakari E, Paakko P, Pietarinen-Runtti P, Kinnula VL. Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. Am J Respir Crit Care Med 2000, 161:615-621.
14. Erzurum SC, Danel C, Gillissen A, Chu CS, Trapnell BC, Crystal RG. In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2. J Appl Physiol 1993, 75:1256-1262.
15. Coursin DB, Cihla HP, Sempf J, Oberley TD, Oberley LW. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 1996, 11:851-860.
16. Ghosh S, Janocha AJ, Aronica MA, Swaidani S, Comhair SA, Xu W, Zheng L, Kaveti S, Kinter M, Hazen SL, Erzurum SC. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J Immunol 2006, 176:5587-5597.
17. Odajima N, Betsuyaku T, Nasuhara Y, Itoh T, Fukuda Y, Senior RM, Nishimura M. Extracellular matrix metalloproteinase inducer in interstitial pneumonias. Hum Pathol 2006, 37:1058-1065. 10.1016/j.humpath.2006.03.006, 16867869.
18. Odajima N, Betsuyaku T, Nasuhara Y, Nishimura M. Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 2007, 55:899-909. 10.1369/jhc.7A7203.2007, 17478448.
19. Ogata M, Wang DH, Ogino K. Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology. Acta Med Okayama 2008, 62:345-361.
20. Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, Senior RM. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 2000, 157:525-535. 1850142, 10934155.
21. Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K, Kondo S, Hamamura I, Hata J, Takahashi H, Nishimura M. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol 2008, 20:349-359. 10.1080/08958370701866412, 18300052.
22. Betsuyaku T, Griffin GL, Watson MA, Senior RM. Laser capture microdissection and real-time reverse transcriptase/polymerase chain reaction of bronchiolar epithelium after bleomycin. Am J Respir Cell Mol Biol 2001, 25:278-284.
23. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988, 41:467-470. 10.1136/jcp.41.4.467, 1141479, 3366935.
24. Tanino Y, Makita H, Miyamoto K, Betsuyaku T, Ohtsuka Y, Nishihira J, Nishimura M. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 283:L156-162.
25. Betsuyaku T, Senior RM. Laser capture microdissection and mRNA characterization of mouse airway epithelium: methodological considerations. Micron 2004, 35:229-234. 10.1016/j.micron.2003.11.015, 15003609.
26. Glare EM, Divjak M, Bailey MI, Walters EH. Beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax 2002, 57:765-770. 10.1136/thorax.57.9.765, 1746418, 12200519.
27. Nagai K, Betsuyaku T, Konno S, Ito Y, Nasuhara Y, Hizawa N, Kondo T, Nishimura M. Diversity of protein carbonylation in allergic airway inflammation. Free Radic Res 2008, 42:921-9. 10.1080/10715760802555585, 19031315.
28. Nagai K, Betsuyaku T, Kondo T, Nasuhara Y, Nishimura M. Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid. Thorax 2006, 61:496-502. 10.1136/thx.2005.049148, 2111210, 16537669.
29. Ogata M. Acatalasemia. Hum Genet 1991, 86:331-340. 10.1007/BF00201829, 1999334.
30. Mata M, Ruíz A, Cerdá M, Martinez-Losa M, Cortijo J, Santangelo F, Serrano-Mollar A, Llombart-Bosch A, Morcillo EJ. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J 2003, 22:900-905. 10.1183/09031936.03.00018003, 14680076.
31. Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003, 138:1037-1048. 10.1038/sj.bjp.0705138, 1573750, 12684259.
32. Yildirim Z, Kotuk M, Erdogan H, Iraz M, Yagmurca M, Kuku I, Fadillioglu E. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res 2006, 40:27-33. 10.1111/j.1600-079X.2005.00272.x, 16313495.
33. Deger Y, Yur F, Ertekin A, Mert N, Dede S, Mert H. Protective effect of alpha-tocopherol on oxidative stress in experimental pulmonary fibrosis in rats. Cell Biochem Funct 2007, 25:633-637. 10.1002/cbf.1362, 16981217.
34. Cavarra E, Carraro F, Fineschi S, Naldini A, Bartalesi B, Pucci A, Lungarella G. Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am J Physiol Lung Cell Mol Physiol 2004, 287:L1186-1192. 10.1152/ajplung.00170.2004, 15321784.
35. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005, 68:1018-1031. 10.1111/j.1523-1755.2005.00494.x, 16105032.
36. Cutroneo KR, White SL, Phan SH, Ehrlich HP. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 2007, 211:585-589. 10.1002/jcp.20972, 17387717.
37. Wang XY, Demelash A, Kim H, Jensen-Taubman S, Dakir el H, Ozbun L, Birrer MJ, Linnoila RI. Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer. Am J Pathol 2009, 175:592-604. 10.2353/ajpath.2009.080461, 2716959, 19608871.
38. Siwik DA, Kuster GM, Brahmbhatt JV, Zaidi Z, Malik J, Ooi H, Ghorayeb G. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes. J Mol Cell Cardiol 2008, 44:210-217. 10.1016/j.yjmcc.2007.07.054, 17869266.
39. Nishikawa M, Tamada A, Hyoudou K, Umeyama Y, Takahashi Y, Kobayashi Y, Kumai H, Ishida E, Staud F, Yabe Y, Takakura Y, Yamashita F, Hashida M. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004, 21:213-221. 10.1023/B:CLIN.0000037706.13747.5e, 15387371.
40. Feinstein RN, Suter H, Jaroslow BN. Blood catalsase polymorphism: some immunological aspects. Science 1968, 159:638-640. 10.1126/science.159.3815.638, 4975476.
41. Shaffer JB, Sutton RB, Bewley GC. Isolation of a cDNA clone for murine catalase and analysis of an acatalasemic mutant. J Biol Chem 1987, 262:12908-12911.
42. Sunami R, Sugiyama H, Wang D, Kobayashi M, Maeshima Y, Yamasaki Y, Masuoka N, Ogawa N, Kira S, Makino H. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 2004, 286:F1030-1038. 10.1152/ajprenal.00266.2003, 14722014.
43. Fukuoka N, Sugiyama H, Inoue T, Kikumoto Y, Takiue K, Morinaga H, Nakao K, Maeshima Y, Asanuma M, Wang DH, Ogino K, Masuoka N, Makino H. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am J Nephrol 2008, 28:661-668. 10.1159/000121357, 18337633.
44. Hay J, Shahzeidi S, Laurent G. Mechanisms of bleomycin-induced lung damage. Arch Toxicol 1991, 65:81-94. 10.1007/BF02034932, 1711838.
45. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008, 294:L152-160. 10.1152/ajplung.00313.2007, 17993587.
46. Schrier DJ, Kunkel RG, Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983, 127:63-66.
47. Haston CK, Tomko TG, Godin N, Kerckhoff L, Hallett MT. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet 2005, 42:464-473. 10.1136/jmg.2004.027938, 1736068, 15937080.
48. Ao X, Lubman DM, Davis MA, Xing X, Kong FM, Lawrence TS, Zhang M. Comparative proteomic analysis of radiation-induced changes in mouse lung: fibrosis-sensitive and -resistant strains. Radiat Res 2008, 169:417-425. 10.1667/RR1173.1, 18363430.
49. Yildirim Z, Kotuk M, Erdogan H, Iraz M, Yagmurca M, Kuku I, Fadillioglu E. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res 2006, 40:27-33. 10.1111/j.1600-079X.2005.00272.x, 16313495.
50. Teixeira KC, Soares FS, Rocha LG, Silveira PC, Silva LA, Valença SS, Dal Pizzol F, Streck EL, Pinho RA. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther 2008, 21:309-16. 10.1016/j.pupt.2007.07.006, 17904883.